Encompass Health Corp financial data

Symbol
EHC on NYSE
Location
Birmingham, AL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 31 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 108% % -13%
Debt-to-equity 166% % -21%
Return On Equity 18% % 5.7%
Return On Assets 8% % 20%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 100,615,977 shares -0.13%
Entity Public Float $8,500,000,000 USD 27%
Common Stock, Value, Issued $1,200,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 100,500,000 shares 0.6%
Weighted Average Number of Shares Outstanding, Diluted 102,300,000 shares 0.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $5,795,600,000 USD 11%
General and Administrative Expense $222,300,000 USD 7%
Costs and Expenses $4,793,600,000 USD 9.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $896,700,000 USD 26%
Income Tax Expense (Benefit) $175,100,000 USD 17%
Net Income (Loss) Attributable to Parent $541,000,000 USD 28%
Earnings Per Share, Basic 5 USD/shares 28%
Earnings Per Share, Diluted 5 USD/shares 28%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $48,700,000 USD -67%
Accounts Receivable, after Allowance for Credit Loss, Current $593,000,000 USD -1.1%
Other Assets, Current $165,300,000 USD 4.2%
Assets, Current $869,800,000 USD -6.9%
Operating Lease, Right-of-Use Asset $218,100,000 USD 4%
Intangible Assets, Net (Excluding Goodwill) $291,900,000 USD -1.5%
Goodwill $1,303,000,000 USD 1.5%
Other Assets, Noncurrent $257,400,000 USD 22%
Assets $6,865,700,000 USD 6.3%
Accounts Payable, Current $138,400,000 USD -19%
Employee-related Liabilities, Current $227,900,000 USD 9.8%
Liabilities, Current $762,000,000 USD -15%
Long-term Debt and Lease Obligation $2,393,900,000 USD 2.1%
Deferred Income Tax Liabilities, Net $107,500,000 USD 11%
Operating Lease, Liability, Noncurrent $202,800,000 USD 3.7%
Other Liabilities, Noncurrent $213,200,000 USD 7.5%
Liabilities $3,679,400,000 USD -1.4%
Retained Earnings (Accumulated Deficit) $796,700,000 USD 96%
Stockholders' Equity Attributable to Parent $2,373,800,000 USD 21%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3,131,900,000 USD 17%
Liabilities and Equity $6,865,700,000 USD 6.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Financing Activities $130,400,000 USD -221%
Net Cash Provided by (Used in) Investing Activities $158,500,000 USD -22%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 116,036,500 shares 0.54%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $300,000 USD -100%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $93,700,000 USD -53%
Deferred Tax Assets, Valuation Allowance $21,000,000 USD -26%
Deferred Tax Assets, Gross $116,000,000 USD -4.8%
Operating Lease, Liability $216,000,000 USD -1.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $541,500,000 USD 28%
Lessee, Operating Lease, Liability, to be Paid $296,800,000 USD -1.1%
Operating Lease, Liability, Current $25,900,000 USD -2.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two $39,600,000 USD 1%
Lessee, Operating Lease, Liability, to be Paid, Year One $38,900,000 USD 5.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) $8,800,000 USD 35%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $80,800,000 USD 1%
Lessee, Operating Lease, Liability, to be Paid, Year Three $37,700,000 USD 0.8%
Deferred Tax Assets, Operating Loss Carryforwards $8,800,000 USD -62%
Lessee, Operating Lease, Liability, to be Paid, Year Four $36,700,000 USD 3.1%
Additional Paid in Capital $1,847,000,000 USD 3.4%
Depreciation, Depletion and Amortization $319,500,000 USD 9.5%
Deferred Tax Assets, Net of Valuation Allowance $95,000,000 USD 1.7%
Share-based Payment Arrangement, Expense $50,600,000 USD 11%
Interest Expense $142,300,000 USD -18%